Why the study?
What are the incidence and risk factors for deep vein thrombosis in patients with acute stroke?
What are the incidence and risk factors for deep vein thrombosis in patients with acute stroke?
Deep vein thrombosis is a frequent and potentially fatal complication in acute stroke patients, particularly those with severe leg paresis and shortened aPTT.
DVT incidence links to higher mortality in acute stroke; leaves open optimal prophylaxis strategies pending randomized data.
To assess the incidence, risk factors, and clinical importance of deep vein thrombosis in acute stroke, we studied 70 consecutive patients who underwent hemostasis screening at the time of entry into the study and followed up these patients with serial venous Doppler examinations and the iodine 125-labeled fibrinogen uptake test. Mortality was significantly higher among the 20 patients who developed a deep vein thrombosis, and eight of them had necropsy evidence of pulmonary embolism. Severity of leg paresis and a shortened activated partial thromboplastin time were significantly associated with subsequent deep vein thrombosis with multivariate analysis. Significantly higher levels of fibrinopeptide A were found in patients with postmortem evidence of pulmonary embolism. Deep vein thrombosis is a frequent complication of acute stroke and may influence the prognosis by inducing pulmonary embolism. Our findings allow rapid identification of high-risk patients who may benefit maximally from prophylactic treatment of venous thromboembolism.
No takes yet. Share an insight, caveat, or question.
G Landi (1992) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: